Presynaptic cholinergic nerve terminal receptor

Presynaptic cholinergic nerve terminal receptors are a heterogeneous group of proteins located on the membranes of cholinergic neurons that modulate the synthesis and release of acetylcholine (ACh) (Source: StatPearls, 2023). The most prominent members are the muscarinic M2 and M4 autoreceptors, which typically provide negative feedback to inhibit further ACh release when synaptic concentrations are high (Source: UniProt P08172, P08173). Additionally, presynaptic nicotinic receptors, such as the alpha-7 or alpha-3-beta-4 subtypes, can act as positive feedback mechanisms to enhance ACh release (Source: PubMed 10672049). These receptors play a critical role in maintaining cholinergic homeostasis in both the central and peripheral nervous systems. Dysregulation of these presynaptic mechanisms is implicated in neurodegenerative conditions such as Alzheimer's disease and various movement disorders (Source: NIH, 2022). Pharmacological targeting of these receptors, particularly with muscarinic antagonists or agonists, is used to treat conditions ranging from bradycardia to cognitive impairment (Source: PubChem). These receptors also serve as heteroreceptors, responding to other neurotransmitters like glutamate or GABA to fine-tune cholinergic output (Source: PubMed).

Other names

Presynaptic muscarinic receptorPresynaptic nicotinic receptorCholinergic autoreceptorPresynaptic acetylcholine receptor

The mechanism of action involves the modulation of acetylcholine release through two primary pathways: activation of presynaptic M2 and M4 muscarinic autoreceptors, which are Gi-coupled and inhibit release via reduction of cAMP and calcium channel activity (Source: StatPearls, 2023); and activation of presynaptic nicotinic receptors, which are ionotropic and facilitate release by promoting cation influx and terminal depolarization (Source: PubMed 10672049).